Methodology for estimating the costs of identifying, diagnosing and treating tuberculosis with multiple and extensive drug resistance

Estimating the cost of treating patients with extensive drug-resistant Mycobacterium tuberculosis is useful both in planning financial resources for anti-tuberculosis activities and in determining the economic burden of this phenomenon. The article proposed the author’s methodology for estimating the costs of identifying, diagnosing and treating tuberculosis with multiple and extensive drug resistance, calculated estimates of the cost of combating the general drug resistance of mycobacteria tuberculosis.

Authors: Obukhova O. V. [28] Sterlikov S. A. [8] Rusakova L. I. [1]

Tags: anti-tuberculosis activity1 direct costs5 dr-tb1 mdr-tb1 multi-drug resistance of mycobacterium tuberculosis1